Turbare Manufacturing

Form 483 issued May 7, 2026 · Conway, Arkansas

Inspection
Apr 20 – May 7, 2026
Observations
4
Pages
13
FEI number
3027507354

In short: On May 7, 2026, FDA issued a Form 483 with 4 observations to Turbare Manufacturing in Conway, Arkansas (FEI 3027507354) after an inspection that ran Apr 20 – May 7, 2026. The investigator was Sangeeta M. Khurana. Most observations concern quality system and production.

At a glance

Quality system and production account for 4 of 4 observations.

Quality system2
Production2

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    The responsibilities and procedures applicable to the quality control unit…

  2. 02

    Procedures designed to prevent microbiological contamination of drug products purporting to be…

  3. 03

    Production personnel were not practicing good…

  4. 04

    There is a failure to thoroughly review any unexplained discrepancy and the failure of a batch…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Turbare Manufacturing?

FDA listed 4 observations on this Form 483, mostly about quality system and production. The opening words of each observation are shown on this page.

Who inspected Turbare Manufacturing?

Sangeeta M. Khurana is named on this Form 483, for the inspection of Apr 20 – May 7, 2026. Each investigator has a profile showing what they cite most.

When was Turbare Manufacturing inspected by FDA?

The inspection ran Apr 20 – May 7, 2026, and the Form 483 is dated May 7, 2026.

How do I get the full Form 483 for Turbare Manufacturing?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free